Author name: Leonardo Arias

As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a message of rebalancing what nations pay to better reflect the innovation and value of drugmaking.

The Renton, Washington-based provider said it’s closer to “breakeven” after implementing efficiency initiatives, including staffing cuts.

WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An attorney explains how the law works, common misconceptions about it and how it helps those about to lose their jobs.

The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new small molecule obesity medications for Lilly.

The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S. government has already spent billions on this work, which has saved millions of lives.

The organizations will collaborate on guidance for community health centers and other safety-net providers, which face increased barriers to implementing AI.

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch for the acute care market next year.

The death was linked to acute kidney injury in a patient who had a single kidney remaining and a “complex medical history,” according to CytomX.

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch for the acute care market next year.

After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be “difficult,” according to Schrödinger, whose stock dropped 17.5% before the opening bell on Thursday.